"Though in my (non-expert) view the market is now over estimating the risk that Imugene's tech will fail, and under estimating the potential reward.
--------
The best tool for non experts to gauge potential is the actions of Big Pharma. Big Pharma don't hesitate to pay squillions for preclinical and/or early clinical companies if they have something special. That's why I'm a bit circumspect on the repetitive hype whipped up here.
Vaccines, page-32
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.4¢ | $417.0K | 9.281M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 6074903 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 362283 | 5 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |